Antimicrobial Susceptibility Testing Market Size, Share, By Product (Automated Laboratory Instruments, Manual Antimicrobial Susceptibility Testing Products, Susceptibility Testing Disks, MIC Strips, Susceptibility Plates, Culture and Growth Media, and Consumables), By Method (Dilution, Disk Diffusion, ETEST, Automated Antimicrobial Susceptibility Testing, and Genotypic Methods), By Application, By End Users, and By Region - Trends, Analysis, and Forecast till 2034

Antimicrobial susceptibility testing market size was valued at USD 4 Billion in 2024 and is expected to reach USD 6.3 Billion by 2034, growing at a CAGR of 5.2%

Antimicrobial susceptibility testing is important to determine resistance for a particular isolate of bacteria as well as verify sensitivity for a particular empiric drug. Resistance screening must be performed through the laboratory for clinical microbiology. Report Phrase Experimental treatment is still successful against certain bacteria despite the face of strategies for resistance (streptococci Python, for instance, remains susceptible to amoxicillin).

Testing are performed to evaluate the possible impact of antibiotic on germs and to figure out if bacteria have evolved immunity to a specific medication. Physicians can pick the drug that is anticipated to prove helpful in treating the particular illness with the assistance of the results of the test, which can provide the possibility of improved medical diagnosis.

                                                For More Report Details, Download Free Sample PDF

Key Drivers of Target Market:

Increasing incidence of infectious diseases.

• There is a significant increase in infectious illnesses such as infections of the urinary tract and swine influenza. To ensure proper prescribing of medicines and to manage various diseases, comprehensive antimicrobial resistance is required. As these illnesses are growing more common, especially in developing nations, there is going to be a demand for reliable AST methods.

Restrains:

High Cost of Testing Equipment and sets

• Some of the more significant obstacles in conducting antibiotic tests for susceptibility the costly aspect of test equipment and supplies, especially for small labs and universities, is the Report Phrase (the AST).
• These economic constraints impede access to prompt diagnosis and treatment alternatives also limit the widespread use of cutting-edge testing technology.

Opportunities:

Technological Advancements

• Next-generation DNA sequencing and genetic developments, combined with additional rapid and automated AST techniques, will speed up results whilst improving patient care. Studies will go more rapidly and more extensively due to the growing need for testing at the point of care.

The market is segmented based on Product, Method, Application, End-User, and Region.

Product Insights:

• Automated Laboratory Instruments: The automatic equipment is utilized for rapid susceptibility testing and organism identification. Utilizing specialized cards that contain enhanced growing medium and antibiotics pertinent to Streptococcus pneumoniae, it can perform rapid susceptibility testing for this bacteria.
• Manual Antimicrobial Susceptibility Testing Products: Antimicrobial susceptibility (AST) supports global and local antimicrobial management through helping clinicians, veterinary professionals, scientists studying food, other health officials in determining pathogenic resistance trends. Our strong, all-inclusive testing services assist customers achieve precise, dependable, reproducible outcomes and simplified workflows, from manual diffusion of the disc to automatic apparatus with actual minimal inhibitory concentration, or MIC, outcomes.
• Susceptibility Testing Disks: Screening for sensitivity Discs are tiny disks made for making it easier to evaluate a living thing's empathy to medicines. Products can be used in medical and industrial settings and are appropriate to assess an extensive range of antibiotics against various microbes.
• MIC Strips: The Minimum Inhibitory Concentration (MIC) of antibiotics that work against bacteria may be measured quantitatively using MIC Test Strips which are additionally useful to find patterns of resistance and suggest the best course of therapy for an individual.
• Susceptibility Plates: A standard quantity of the microorganism is subjected to different doses of antibiotics in sensitivity evaluation to identify the microbe's sensitivity to those medicines. It is possible to test for fungi, viruses, and bacteria. Outcomes with a single drug may be employed to anticipate results from comparable medications with specific species.
• Culture and Growth Media: Cultural media is a filled with nutrients gel or liquid that is used to cultivate microorganisms like bacteria. Another term for these is growth media. Various types of medium are used to grow various types of cells. Agar-based plates or nutritional broths are the most popular media for growth utilized by bacteria.
• Consumables: Around the world, antimicrobial resistance, or has become an important threat to public health. Preventing the development and spread of antimicrobial resistance (AMR) requires timely and precise identification of drug resistant antibiotics, effective antimicrobial therapy, and antimicrobial management.

Method Insights:

• Dilution: Dilution: The dilution testing serves to objectively ascertain the smallest amount of antimicrobial substance (in milligrams per required for inhibition or eliminate the bacterium. An agar pour, a broth tube, or a micro-broth screen is disinfected by directly applying twofold dilutions of the antimicrobial substance.
• Disk Diffusion: A culture-based microbiology test utilized by diagnosis and drug development labs is the disk diffusion test, also known as the agar diffusion test, Kirby-Bauer test, disc-diffusion antibiotic susceptibility test, disc-diffusion antibiotic susceptibility test, and KB testing.
• ETEST: Using the agar dilution technique as a norm, the research sought to confirm the Epsilometer test (E-test) method for antimicrobial susceptibility evaluation of specific periodontopathic bacteria. The E-test was created to give an accurate assessment of an organism's empathy to antibiotics.
• Automated Antimicrobial Susceptibility Testing: Assessing a bacterial sensitivity to medicines is referred to as testing for antibiotic sensitivity and antimicrobial susceptibility testing for short. It is used due to the potential of resistance to antibiotics in microorganisms.
• Genotypic Methods: By analyzing someone's DNA genome using biological tests and comparing it to the DNA sequence of someone else or an earlier order, genotyping is the process of recognizing differences in a person's genetic makeup (genotype). It demonstrates the alleles that someone has inherited from their grandparents. Historically, genotyping has involved using chemical methods to define populations of organisms based on the sequence of DNA. Typically, it does not involve identifying an individual's biological makeup.

Application Insights:

• Antibacterial Testing: Antibacterial are medicines that treat illnesses caused by bacteria, as well as certain fungi. They are not effective for infections caused by viruses. Different medicines possess distinct modes of action against various types of microorganisms or fungi. The most effective antibiotics for managing the infection may be identified through a test for antimicrobial sensitivity.
• Antifungal Testing: In medical microbiology labs, bacterial susceptibility screening and testing for antifungal susceptibility (AFST) have become increasingly essential tools. The objective of AFST is to consistently produce MIC values that can be used to monitor the prevalence of antifungal drug resistance, support research into epidemiology, and improve patient care. Standard organizations for development have universally adopted the following methods for testing for Aspergillus: azole agar, disk diffusion, and broth dilution.
• Antiparasitic Testing: A group of drugs called antiparasitic drugs is used to treat and manage infections triggered by parasitic organisms, including helminths, parasites, or amoeba. Many pharmaceutical classes which treat an array of parasite-caused disorders are categorized as antiparasitic medications. For indications, ways of action, side effects, and precautions of numerous types of antiparasitic medicines are outlined in this process. These medicines are useful in the management of diseases like scabies, bacterial, malaria, and malaria.
• Others Susceptibility Testing: The industry for antimicrobial susceptibility tests involves an array of methods for testing, such as anti-fungal, antibacterial, and antiparasitic testing that are crucial to assessing how well therapies work versus diseases. These methods of diagnosis have become essential for directing appropriate therapy and enhancing the health of patients in clinical settings due to the growth in antimicrobial resistance and the growing occurrence of infectious diseases.

End User Insights:

• Diagnostic Centers and Hospitals: For the purpose to encourage the prudent consumption of antibiotics, hospital and medical centers need accessibility to the antimicrobial susceptibility testing (AST) market. These assessments let medical personnel choose the most effective course for treatment by revealing resistance profiles for various infections, decreasing the development of resistant infections to antibiotics and improves treatment for patients.
• Pharmaceutical and Biotechnology Companies: The marketplace for antibiotic susceptibility testing (AST) is essential to assess the extent to which antibiotics work against infections, and supports efforts that fight resistance to antibiotics. Biotechnology and pharmaceutical firms depend on AST to create new antibiotics and improve methods for therapy, guaranteeing the medications is effective and precisely focused.
• Contract Research Organizations (CROs): Testing for antimicrobial susceptibility (the AST) has grown increasingly vital in order for satisfying clinical or pharmaceutical needs by finding successful therapies for resistance infections caused by bacteria. With this sector, contract research organizations (CROs) are crucial because they offer specialised testing services to assist pharmaceutical businesses in creating new antibiotics whilst complying with regulatory guidelines.
• Research and Academic Institutes: Research-capable institutions perform an important part in the antimicrobial resistance test (AST) industry through the creation of novel methods for testing and increasing knowledge in science. By assisting, medical professionals will be in a better position to identify problematic clients, select the most appropriate method of treatment with antibiotics, and battle the grave problem of antimicrobial resistance.

Regional Insights:

• North America: North America has been influenced by an increase in the incidence of infections caused by antibiotic-resistant bacteria and the growing understanding of the need to use medicines properly. Major expenditures in research and an excellent health care system aid the industry and promote the sector's development.
• Asia Pacific: The development in resistance to antibiotics and increasing medical expenses are driving a significant expansion of the antimicrobial susceptibility testing (AST) market in the Asia Pacific region.
• Europe: Antimicrobial susceptibility testing (AST) is a market that is rapidly growing in the Asia-Pacific region due to rising medical costs and the development of resistance to antibiotics.
• Latin America: Antimicrobial (AST) test demand will likely increase sharply in Europe due to an increase in diseases resistant to antibiotics and a greater demand for rapid testing for diagnosis.
• Middle East and Africa: It is expected that the Targeted will rise significantly due to the increasing prevalence and infectious illnesses and the rising need for efficient prevention and treatment. In addition, the necessity for precise, fast susceptibility testing has increased primarily a result of recent advances in medical technology and a growing focus on personalized treatment.

Antimicrobial Susceptibility Testing Market Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study segmented the target market report based on Product, Method, Application, End-User, and Region.

Segmentation:

By Product:

• Automated Laboratory Instruments
• Manual Antimicrobial Susceptibility Testing Products
• Susceptibility Testing Disks
• MIC Strips
• Susceptibility Plates
• Culture and Growth Media
• Consumables

By Method:

• Dilution
• Disk Diffusion
• ETEST
• Automated Antimicrobial Susceptibility Testing
• Genotypic Methods

By Application:

• Antibacterial Testing
• Antifungal Testing
• Antiparasitic Testing
• Others Susceptibility Testing

By End User:

• Diagnostic Centers and Hospitals
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Research and Academic Institutes

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the antimicrobial susceptibility testing market include BioMérieux S.A., Hi Media Laboratories, Alifax Holding S.p.A., Creative Diagnostics, Resistell AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories, and F. Hoffmann-La Roche Ltd.

                                    To Access More Companies, Request Free Sample Report

• In May 2022, Qualigen Therapeutics, Inc. A diversified life sciences organization focused on development treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, announces that NanoSynex Ltd, a company with which Qualigen recently entered into definitive agreements to acquire a majority stake.
• In April 2022, COPAN Diagnostics (Murrieta, CA, USA) presented a variety of fully computerized technologies at the 32nd European Conference of Medical Microbiology & Infectious Diseases (ECCMID 2022) for identifying & detection of antimicrobial susceptibility (AST) in the field of clinical microbiology.

• BioMérieux S.A.
• Hi Media Laboratories
• Alifax Holding S.p.A.
• Creative Diagnostics
• Resistell AG
• Danaher Corporation
• Becton
• Dickinson and Company
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Bio-Rad Laboratories
• F. Hoffmann-La Roche Ltd.